Low-Contrast Visual Tests Reveal Better Alemtuzumab Efficacy

Standard visual acuity testing misses some visual dysfunction in patients with MS. Sloan low-contrast acuity testing revealed superior efficacy for alemtuzumab over interferon beta-1a in CARE-MS I.
Medscape Medical News

Full Story →